Vonoprazan FuMarate

Vonoprazan FuMarate Struktur
881681-01-2
CAS-Nr.
881681-01-2
Englisch Name:
Vonoprazan FuMarate
Synonyma:
Vonoprazan Fumurate;5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine (2E)-2-butenedioate;Voranomazin;TAK-438,Takecab;TAK438 Fumarate;TAK 438 Fumarate;TAK-438 Fumarate;Fumarate vonorazan;Vonoprazan FuMarat;Vonorazan Fumarate
CBNumber:
CB52716735
Summenformel:
C21H20FN3O6S
Molgewicht:
461.46
MOL-Datei:
881681-01-2.mol

Vonoprazan FuMarate Eigenschaften

storage temp. 
Store at -20°C
Löslichkeit
DMSO: 50 mg/mL (108.35 mM)
Aggregatzustand
Solid
Farbe
White to Off-White
InChIKey
ROGSHYHKHPCCJW-WLHGVMLRSA-N
SMILES
C(/C(=O)O)=C\C(=O)O.S(C1=CN=CC=C1)(N1C=C(CNC)C=C1C1C=CC=CC=1F)(=O)=O
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H302 Gesundheitsschädlich bei Verschlucken. Akute Toxizität oral Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P270, P301+P312, P330, P501
H315 Verursacht Hautreizungen. Hautreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P302+P352, P321,P332+P313, P362
H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P305+P351+P338,P337+P313P
H335 Kann die Atemwege reizen. Spezifische Zielorgan-Toxizität (einmalige Exposition) Kategorie 3 (Atemwegsreizung) Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" />
Sicherheit
P261 Einatmen von Staub vermeiden.
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.

Vonoprazan FuMarate Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Vonoprazan fumarate is white to nearly white crystals or crystalline powder which melts at 194.8°C . It can be dissolved in dimethyl sulfoxide, but has limited solubility in N,N-dimethylacetamide, N,N-dimethylformamide, methanol, and water. It is only slightly soluble in ethanol (99.5%), and has very low solubility in 2-propanol, acetone, 1-octanol, and acetonitrile.

benefits

Compared with traditional irreversible proton pump inhibitors (such as omeprazole, esomeprazole, etc.), Vonoprazan fumarate advantages:
① The onset of action is good, and the maximum acid-suppressing effect will be achieved on the first day of administration;
② Oral administration, not affected by gastric acid damage;
③It can improve the phenomenon of acid breakthrough at night.

Allgemeine Beschreibung

Vonoprazan fumarate (TAK-438) is a new oral anti-gastric acid drug jointly launched by Takeda Pharmaceutical and Otsuka Pharmaceutical. It can be used for the treatment of erosive esophagitis, gastric ulcer and duodenal ulcer.

Mechanism of action

Vonoprazan fumarate is a potassium ion (K+) competitive acid blocker (P-CAB), which is a reversible proton pump inhibitor. It can inhibit the combination of K+ and H+-K+-ATPase (proton pump), so that secretion of gastric acid is terminated. Vonoprazan fumarate has a strong and lasting inhibitory effect on gastric acid secretion.

Synthese

Vonoprazan FuMarate is prepared by the reaction of vonoprazan and (2E)-but-2-enedioic acid. The steps are as follows:
Step 1: (2E)-but-2-enedioic acid With sodium hydroxide In water at 50 - 60℃.
Step 2: vonoprazan In water; toluene at 25 - 35℃; Reagent/catalyst.
Add 730g of water and 73g of fumaric acid to a 2L reaction flask at 5060, stir and disperse, control the temperature between 5060, add 25g of hydrogen hydroxide dropwise to the fumaric acid suspension The solution of sodium and 300 g of water was gradually dissolved in the system during the dropwise addition, and the aqueous solution of compound was obtained and kept for use.Between 25 and 35°C, take half of the toluene solution of compound obtained in the previous step and put it into a 5L reaction flask, and add the aqueous solution of the above compound dropwise to it. During the dropwise addition, the system has a white solid precipitation. After the dropwise addition was completed, keep stirring for 2-4 hours, filter, and dry the filter cake at 50°C to obtain 131.32 g of white solid, the HPLC purity was 99.96%, and the yield was 94%.
Vonoprazan FuMarate synthesis

Vonoprazan FuMarate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Vonoprazan FuMarate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 165)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Zhuhai Hairuide Bioscience and Technology Co., Ltd
+8618928027945
sales3@zhhairuide.com China 97 58
LEAPCHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 43348 58
shandong perfect biotechnology co.ltd
+86-53169958659; +8618596095638
sales@sdperfect.com China 294 58
Hebei Xinsheng New Material Technology Co., LTD.
+86-16632316109
xinshengkeji@xsmaterial.com China 1100 58
Beijing Cooperate Pharmaceutical Co.,Ltd
010-60279497
sales01@cooperate-pharm.com CHINA 1811 55
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
Jinan Shengqi pharmaceutical Co,Ltd
86+18663751872
christine@shengqipharm.com CHINA 491 58
HubeiwidelychemicaltechnologyCo.,Ltd
18627774460
faith@widelychemical.com CHINA 742 58
Chongqing Chemdad Co., Ltd
+86-023-6139-8061 +86-86-13650506873
sales@chemdad.com China 39916 58
Shaanxi Dideu Medichem Co. Ltd
+86-29-87569265 +86-18612256290
1056@dideu.com China 2929 58

  • Vonoprazan FuMarate###NA
  • 1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate
  • Vonoprazan-025-Salt1
  • Voranomazin
  • Vonoprazan FuMarate USP/EP/BP
  • Vonoprazan fumarate,TAK-438,Takecab
  • Vonoprazan fumarate 13C D3
  • Fumarate vonorazan
  • 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine (2E)-2-butenedioate
  • Vonoprazan Fumurate
  • 5-(2- fluorophenyl) -N- methyl -1-(3- pyridylsulfonyl) -1H- pyrrole -3- methylamine fumarate
  • Vonoprazan FuMarat
  • Vonorazan Fumarate
  • 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate? (Vonoprazan Impurity)
  • 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine (2E)-2-butenedioate (1:1)
  • peptic,potassium,secretion,reflux,competitive,Vonoprazan Fumarate,proton,inhibitor,antisecretory,disease,gastroesophageal,inhibit,Vonoprazan,ulcer,GERD,blocker,acid,gastric,pump,P-CAB,Proton Pump
  • 5-(2-Fluorophenyl)-N-methyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-methanamine fumarate (1:1)
  • TAK-438,Takecab
  • Vonoprazan Fumarate In-House
  • TAK 438 Fumarate
  • TAK438 Fumarate
  • TAK-438 Fumarate
  • 881681-01-2
Copyright 2019 © ChemicalBook. All rights reserved